Cyclosporine A enables vincristine-induced apoptosis during reversal of multidrug resistance phenotype in chronic myeloid leukemia cells

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Tumor Biology

• Publication date

  2012-01-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s13277-012-0323-5PMID 22290425
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• P-glycoprotein and survivin simultaneously regulate vincristine-induced apoptosis in chronic myeloid leukemia cells.

  2011cited by this paper
• Simultaneous targeting of P‐gp and XIAP with siRNAs increases sensitivity of P‐gp overexpressing CML cells to imatinib

  2011cited by this paper
• Variation of MDR proteins expression and activity levels according to clinical status and evolution of CML patients

  2011cited by this paper
• Survivin overexpression correlates with an apoptosis-resistant phenotype in chronic myeloid leukemia cells.

  2011cited by this paper
• Survivin and P-glycoprotein are associated and highly expressed in late phase chronic myeloid leukemia.

  2011cited by this paper
• Inhibition of HIF-1alpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis

  2009cited by this paper
• Cyclosporin A sensitises Bcr-Abl positive cells to imatinib mesylate independently of P-glycoprotein expression.

  2009cited by this paper
• Multidrug resistant P-glycoprotein positive L1210/VCR cells are also cross-resistant to cisplatin via a mechanism distinct from P-glycoprotein-mediated drug efflux activity.

  2009cited by this paper
• Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma.

  2009cited by this paper
• siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cells

  2009cited by this paper
• Expression of the Uptake Drug Transporter hOCT1 is an Important Clinical Determinant of the Response to Imatinib in Chronic Myeloid Leukemia

  2008cited by this paper
• ABC multidrug transporters: structure, function and role in chemoresistance.

  2008cited by this paper
• Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics

  2008cited by this paper
• Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies.

  2008cited by this paper
• Cancer cells survive with survivin

  2008cited by this paper
• Expression of multidrug resistance‐associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin

  2008cited by this paper
• Taxanes, microtubules and chemoresistant breast cancer.

  2008cited by this paper
• Expression of Multidrug Resistance 1 (MDR1), Multidrug Resistance-Related Protein 1 (MRP1), Lung Resistance Protein (LRP), and Breast Cancer Resistance Protein (BCRP) Genes and Clinical Outcome in Childhood Acute Lymphoblastic Leukemia

  2007cited by this paper
• ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra?

  2007cited by this paper
• Contrasting features of MDR phenotype in leukemias by using two fluorochromes: implications for clinical practice.

  2007cited by this paper
• The effect of survivin on multidrug resistance mediated by P-glycoprotein in MCF-7 and its adriamycin resistant cells.

  2007cited by this paper
• Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cells

  2007cited by this paper
• Survivin, a cancer target with an emerging role in normal adult tissues

  2006cited by this paper
• Targeting XIAP for the treatment of malignancy

  2006cited by this paper
• Apoptosis, necrosis and cell proliferation-inhibition by cyclosporine A in U937 cells (a human monocytic cell line).

  2006cited by this paper
• IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy‐induced overexpression of multidrug resistance genes

  2006cited by this paper
• Phase III study of PSC‐833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95)

  2006cited by this paper
• Cyclosporin A Is a Broad-Spectrum Multidrug Resistance Modulator

  2005cited by this paper
• lymphomas clinical response to chemotherapy in primary nodal diffuse large B-cell Immunohistochemical profiling of caspase signaling pathways predicts

  2005cited by this paper
• Comparison of Chemotherapy Response with P-Glycoprotein, Multidrug Resistance-Related Protein-1, and Lung Resistance-Related Protein Expression in Untreated Small Cell Lung Cancer

  2005cited by this paper
• The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure

  2005cited by this paper
• Importance of P-glycoprotein at blood-tissue barriers.

  2004cited by this paper
• P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate

  2004cited by this paper
• Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.

  2004cited by this paper
• Pheophorbide a Is a Specific Probe for ABCG2 Function and Inhibition

  2004cited by this paper
• Expression of the IAPs in multidrug resistant tumor cells.

  2004cited by this paper
• The Molecular Mysteries Underlying P-glycoprotein-Mediated Multidrug Resistance

  2004cited by this paper
• Introduction to resistance to anticancer agents

  2003cited by this paper
• A high-throughput screening microplate test for the interaction of drugs with P-glycoprotein.

  2002cited by this paper
• Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins).

  2002cited by this paper
• Multidrug resistance in tumour cells: characterization of the multidrug resistant cell line K562-Lucena 1.

  2001cited by this paper
• Cells from chronic myelogenous leukaemia patients at presentation exhibit multidrug resistance not mediated by either MDR1 or MRP1

  2001cited by this paper
• The human ATP-binding cassette (ABC) transporter superfamily.

  2001cited by this paper
• The human ATP-binding cassette (ABC) transporter superfamily.

  2001cited by this paper
• Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study.

  2001cited by this paper
• Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line

  1999cited by this paper
• Apoptosis and necrosis: mechanisms of cell death induced by cyclosporine A in a renal proximal tubular cell line.

  1998cited by this paper
• The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate.

  1994cited by this paper
• Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance.

  1994cited by this paper
• Human P-glycoprotein transports cyclosporin A and FK506.

  1993cited by this paper
• Modulators of P-glycoprotein-associated multidrug resistance.

  1991cited by this paper

• Quercetin Increased the Sensitivity of Cisplatin-resistant Bladder Cancer Cells to Cisplatin Through the Bim-Bak / Bax Pathway

  2017cites this paper
• Salinomycin enhances doxorubicin-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin

  2015cites this paper
• Microparticles induce multifactorial resistance through oncogenic pathways independently of cancer cell type

  2014cites this paper
• β-Elemene, a compound derived from Rhizoma zedoariae, reverses multidrug resistance mediated by the ABCB1 transporter.

  2014cites this paper
• Yeast ABC proteins involved in multidrug resistance

  2013cites this paper
• Cianfriglia Targeting MDR 1P-glycoprotein ( MDR 1-Pgp ) in immunochemotherapy of acute myeloid leukemia ( AML )

  2013cites this paper
• Targeting MDR1-P-glycoprotein (MDR1-Pgp) in immunochemotherapy of acute myeloid leukemia (AML).

  2013cites this paper
• Yeast as a biosensor of detoxification: a tool for identifying new compounds that revert multidrug resistance.

  2013cites this paper
• HG-829 is a potent noncompetitive inhibitor of the ATP-binding cassette multidrug resistance transporter ABCB1.

  2012cites this paper
• Differentiation and Cell Survival of Myeloid Leukemia Cells

  2012cites this paper
• The Interface between BCR-ABL-Dependent and -Independent Resistance Signaling Pathways in Chronic Myeloid Leukemia

  2012cites this paper
• IMPROVING DELIVERY OF ELACRIDAR TO ENHANCE EFFICACY OF MOLECULARLY-TARGETED AGENTS IN TREATMENT OF GLIOBLASTOMA

  2012cites this paper